MDXG
MiMedx Group IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$537.69M
P/E Ratio
18.05
EPS
$0.20
Beta
1.46
52W High
$7.99
52W Low
$3.03
50-Day MA
$4.09
200-Day MA
$6.02
Dividend Yield
—
Profit Margin
7.88%
Forward P/E
18.32
PEG Ratio
2.88
About MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
Fundamentals
| Revenue (TTM) | $389.42M |
| Gross Profit (TTM) | $315.59M |
| EBITDA | $52.88M |
| Operating Margin | -27.20% |
| Return on Equity | 13.80% |
| Return on Assets | 8.55% |
| Revenue/Share (TTM) | $2.63 |
| Book Value | $1.73 |
| Price-to-Book | 2.27 |
| Price-to-Sales (TTM) | 1.38 |
| EV/Revenue | 1.048 |
| EV/EBITDA | 7.68 |
| Quarterly Earnings Growth (YoY) | 99.50% |
| Quarterly Revenue Growth (YoY) | -33.10% |
| Shares Outstanding | $148.95M |
| Float | $117.91M |
| % Insiders | 1.94% |
| % Institutions | 73.05% |
Historical Volatility
HV 10-Day
87.58%
HV 20-Day
80.50%
HV 30-Day
68.30%
HV 60-Day
53.37%
HV Rank
100.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($6.50 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026